DR. RAHUL RAVILLA M.D NPI 1003171778

NPI Information

  • NPI: 1003171778
  • Provider Name: DR. RAHUL RAVILLA, M.D
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 43 NEW SCOTLAND AVE STE 7
    ALBANY, NY
    ZIP 12208
  • Phone: (518) 262-6696

Map and Directions

Get Directions

NPI Details

DR. Rahul Ravilla, M.D is a hematology and oncology internal medicine in Albany, NY with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Rahul Ravilla, M.D NPI is 1003171778. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

43 NEW SCOTLAND AVE STE 7
ALBANY, NY
ZIP 12208-412
Phone: (518) 262-6696
Fax: (518) 262-2624

The NPI 1003171778 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Magnesium level (HCPCS:83735)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Urinalysis, manual test (HCPCS:81002)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Unclassified drugs (HCPCS:J3490)
  • Iron level (HCPCS:83540)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Iron binding capacity (HCPCS:83550)

The enumeration date for this NPI number is 7/9/2012 and was last updated on 6/28/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology294216NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.